Clinical Trial Update: Study to Evaluate Weight-based Enoxaparin Dosing in Obese Medical Patients at Risk for DVT [Phase 4]

View source ↗

Summary

Phase 4 study evaluating weight-based dosing of enoxaparin in obese medical patients at risk for deep vein thrombosis has completed, with results posted in 2011…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Venous Thromboembolism

Drugs mentioned

• Lovenox (enoxaparin)

Snippet

Sponsor: University of Utah | Conditions: Obesity, Venous Thrombosis | Phase 4 | Status: COMPLETED | Results posted: 2011-09-05